Nano-treatment for eye diseases

Israel’s BioNanoSim (see here previously) is joining forces with Greek-based manufacturer RAFARM, to market BioNanoSim’s eye disease treatments globally. Its product, BNSO-1, is a topical medication that will shortly begin trials on patients suffering from Chronic Anterior Uveitis.

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *